2011
DOI: 10.2149/tmh.2011-s08
|View full text |Cite
|
Sign up to set email alerts
|

Host genetic susceptibility to severe dengue infection

Abstract: Epidemiological evidence indicates that host genetic factors are relevant and predispose DHF/DSS development. Here, we review the host genetic studies concerning human leucocyte antigens, antibody receptors, immune/inflammatory mediators, attachment molecules, cytokines and other factors exerting an immunoregulatory effect as well as the current genome-wide association studies. We also discuss some viewpoints on future challenges related to the design of safe and effective prevention and treatment options.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
28
0
3

Year Published

2012
2012
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(34 citation statements)
references
References 52 publications
1
28
0
3
Order By: Relevance
“…DHF is clinically characterized by bleeding and plasma leak, and a severe DHF leads to hypovolemia and even circulatory collapse in the affected patient, which is known as dengue shock syndrome (DSS) [1, 2]. Well-documented risk factors for DHF include secondary infection caused by a DENV serotype which differs from that responsible for the prior dengue episode [3, 4], the genetic predilection for causing hemorrhage of the culprit DENV [5, 6], the genetic predisposing for hemorrhage of the dengue patient [7], the aging of the host [8, 9], and diabetes mellitus (DM) [1013]. DM is a multifaceted disease that implicates metabolic derangements and immune dysfunction [14].…”
Section: Introductionmentioning
confidence: 99%
“…DHF is clinically characterized by bleeding and plasma leak, and a severe DHF leads to hypovolemia and even circulatory collapse in the affected patient, which is known as dengue shock syndrome (DSS) [1, 2]. Well-documented risk factors for DHF include secondary infection caused by a DENV serotype which differs from that responsible for the prior dengue episode [3, 4], the genetic predilection for causing hemorrhage of the culprit DENV [5, 6], the genetic predisposing for hemorrhage of the dengue patient [7], the aging of the host [8, 9], and diabetes mellitus (DM) [1013]. DM is a multifaceted disease that implicates metabolic derangements and immune dysfunction [14].…”
Section: Introductionmentioning
confidence: 99%
“…The observation that African ancestry was associated with protection against DHF and DSS in Cuba and Brazil indicates a major role for host genetic variations in determining the clinical outcome of DENV infection [3,4]. The association of variants of human leukocyte antigen class I and class II genes, tumor necrosis factor (TNF)-a, CD209, FcGRIIA, vitamin D receptor (VDR), transporters associated with antigen presentation (TAP) and JAK1 genes with disease severity in dengue have been reported [5].…”
Section: Introductionmentioning
confidence: 99%
“…Las variantes rs1800750, rs2069843 y rs2069705 se tipificaron mediante ensayos de reacción en cadena de la polimerasa combinados con polimorfismos en la longitud de fragmentos de restricción (PCR-RFLP). Los genes candidatos se seleccionaron con base en los estudios de fisiopatología del dengue citados en la introducción (11)(12)(13)(14)(15)(16)(17)(18)(20)(21)(22)24,26). Los cebadores utilizados están detallados en el cuadro suplementario 1.…”
Section: Extracción De Adn Y Tipificación De Variantes En Genes Candiunclassified
“…La expresión de los genes TNFA, IL6 e IFNG fue elevada en casos de dengue hemorrágico, pero este grupo de transcriptos no siempre se expresaron en el mismo grupo étnico (16,17).…”
unclassified